Detalhe da pesquisa
1.
Durable response of therapy-related MDS/AML with concomitant Waldenström's macroglobulinemia treated with venetoclax and azacitidine.
Ann Hematol
; 101(7): 1587-1589, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35187605
2.
Prognostic value of post-treatment serum soluble interleukin-2 receptor in newly diagnosed diffuse large B-cell lymphoma patients who achieved complete metabolic response following R-CHOP therapy.
Sci Rep
; 13(1): 13713, 2023 08 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-37608029
3.
Serum cell-free DNA concentration as a possible prognostic marker in newly diagnosed diffuse large B-cell lymphoma.
Biomed Res
; 43(4): 99-106, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35989290